Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 327

1.

Low dose daily versus on-demand high dose tadalafil in diabetic patients with erectile and ejaculatory dysfunction.

Bolat MS, Cinar O, Akdeniz E, Aşcı R.

Int J Impot Res. 2018 Jun;30(3):102-107. doi: 10.1038/s41443-018-0019-5. Epub 2018 May 25.

PMID:
29795527
2.

[Effects of different medications with tadalafil on erectile dysfunction in males with primary sexual failure].

Li WJ, Xu MX, Guo JH, Cai ZK, Jiang YQ, Wang Z.

Zhonghua Nan Ke Xue. 2017 Jun;23(6):522-526. Chinese.

PMID:
29722944
3.

Comparison of tadalafil pharmacokinetics after administration of a new orodispersible film versus a film-coated tablet.

Park SI, Heo SH, Kim G, Chang S, Song KH, Kim MG, Jin EH, Kim J, Lee S, Hong JH.

Drug Des Devel Ther. 2018 Apr 20;12:935-942. doi: 10.2147/DDDT.S155040. eCollection 2018.

4.
5.

Acute tadalafil administration increases plasma fatty acids without changes in the inflammatory response in healthy men.

Ceci R, Duranti G, Sgrò P, Sabatini S, Di Luigi L.

Acta Biochim Pol. 2017;64(4):687-691. doi: 10.18388/abp.2017_2205. Epub 2017 Dec 5.

6.

Comparison of the therapeutic effects and side effects of tadalafil and sildenafil after surgery in young infants with pulmonary arterial hypertension due to systemic-to-pulmonary shunts.

Sabri MR, Bigdelian H, Hosseinzadeh M, Ahmadi A, Ghaderian M, Shoja M.

Cardiol Young. 2017 Nov;27(9):1686-1693. doi: 10.1017/S1047951117000981.

PMID:
28994364
7.

A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy.

Victor RG, Sweeney HL, Finkel R, McDonald CM, Byrne B, Eagle M, Goemans N, Vandenborne K, Dubrovsky AL, Topaloglu H, Miceli MC, Furlong P, Landry J, Elashoff R, Cox D; Tadalafil DMD Study Group.

Neurology. 2017 Oct 24;89(17):1811-1820. doi: 10.1212/WNL.0000000000004570. Epub 2017 Sep 29.

8.

Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.

Kim SW, Park NC, Lee SW, Yang DY, Park JK, Moon DG, Yang SK, Lee SW, Moon KH, Ahn TY, Kim SW, Park K, Min KS, Ryu JK, Son H, Jung J, Hyun JS.

J Sex Med. 2017 Aug;14(8):1018-1027. doi: 10.1016/j.jsxm.2017.06.006.

PMID:
28760246
9.

The efficacy of low-dose tadalafil in patients undergoing hemodialysis with end-stage renal disease.

Bolat MS, Özer İ, Cinar O, Akdeniz E, Aşcı R.

Ren Fail. 2017 Nov;39(1):582-587. doi: 10.1080/0886022X.2017.1349678.

PMID:
28742406
10.

Audiometry results and TEOAE and DPOAE amplitudes in men taking a phosphodiesterase type 5 inhibitor for erectile dysfunction.

Öntepeli S, Muluk NB, Tuğlu D, Şipal T.

Ear Nose Throat J. 2017 Jul;96(7):E34-E39.

PMID:
28719717
11.

Safety and dose-finding trial of tadalafil administered for fetal growth restriction: A phase-1 clinical study.

Kubo M, Tanaka H, Maki S, Nii M, Murabayashi N, Osato K, Kamimoto Y, Umekawa T, Kondo E, Ikeda T.

J Obstet Gynaecol Res. 2017 Jul;43(7):1159-1168. doi: 10.1111/jog.13345.

PMID:
28718213
12.

Chitosan membranes applied on the prostatic neurovascular bundles after nerve-sparing robot-assisted radical prostatectomy: a phase II study.

Porpiglia F, Bertolo R, Fiori C, Manfredi M, De Cillis S, Geuna S.

BJU Int. 2018 Mar;121(3):472-478. doi: 10.1111/bju.13959. Epub 2017 Aug 9.

PMID:
28710845
13.

Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function - A multi-center, double-blind, randomized, placebo-controlled clinical trial - SERVE trial - Rational and design.

Tobler D, Bouchardy J, Reto E, Heg D, Müller C, Frenk A, Gabriel H, Schwitter J, Rutz T, Buechel RR, Willhelm M, Trachsel L, Freese M, Greutmann M, Schwerzmann M; SERVE trial.

Int J Cardiol. 2017 Sep 15;243:354-359. doi: 10.1016/j.ijcard.2017.05.079. Epub 2017 May 23.

PMID:
28566262
14.

Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trial.

Pauls MMH, Clarke N, Trippier S, Betteridge S, Howe FA, Khan U, Kruuse C, Madigan JB, Moynihan B, Pereira AC, Rolfe D, Rostrup E, Haig CE, Barrick TR, Isaacs JD, Hainsworth AH.

Trials. 2017 May 22;18(1):229. doi: 10.1186/s13063-017-1973-9.

15.

Comparison of Silodosin versus Tadalafil in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.

Yoshida M, Origasa H, Seki N.

Low Urin Tract Symptoms. 2017 Sep;9(3):176-186. doi: 10.1111/luts.12177. Epub 2017 Apr 25.

PMID:
28439987
16.

Clinical and hemodynamic improvements after adding ambrisentan to background PDE5i therapy in patients with pulmonary arterial hypertension exhibiting a suboptimal therapeutic response (ATHENA-1).

Shapiro S, Torres F, Feldman J, Keogh A, Allard M, Blair C, Gillies H, Tislow J, Oudiz RJ.

Respir Med. 2017 May;126:84-92. doi: 10.1016/j.rmed.2017.03.025. Epub 2017 Mar 29.

PMID:
28427554
17.
18.

Effects of taking tadalafil 5 mg once daily on erectile function and total testosterone levels in patients with metabolic syndrome.

Ozcan L, Polat EC, Kocaaslan R, Onen E, Otunctemur A, Ozbek E.

Andrologia. 2017 Nov;49(9). doi: 10.1111/and.12751. Epub 2017 Mar 15.

PMID:
28295481
19.

Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease.

Galiè N, Denton CP, Dardi F, Manes A, Mazzanti G, Li B, Varanese L, Esler A, Harmon C, Palazzini M.

Int J Cardiol. 2017 May 15;235:67-72. doi: 10.1016/j.ijcard.2017.02.094. Epub 2017 Feb 22.

PMID:
28279499
20.

Effect of tadalafil administration on insulin secretion and insulin sensitivity in obese men.

González-Ortiz M, Martínez-Abundis E, Hernández-Corona DM, Ramírez-Rodríguez AM.

Acta Clin Belg. 2017 Oct;72(5):326-330. doi: 10.1080/17843286.2017.1293759. Epub 2017 Feb 28.

PMID:
28245726

Supplemental Content

Loading ...
Support Center